The in vitro activities of imipenem, aztreonam, piperacillin, ciprofloxacin and amikacin were tested by the microbroth dilution technique against 86 clinical isolates of Pseudomonas aeruginosa. Imipenem and ciprofloxacin were the most active agents against gentamicin-susceptible P. aeruginosa. Only imipenem inhibited gentamicin-resistant P. aeruginosa at less than or equal to 8 mu g/ml. The finding that none of the gentamicin-resistant strains were resistant to imipenem and amikacin indicated the superiority of these antibiotics to the other agents in hospital-associated gentamicin-resistant P. aeruginosa infections
ABSTRACTÂ We studied the susceptibility of 88 non-repetitive clinical isolates of Pseudomonas aerugi...
Emergence of resistance to fluoroquinolones was observed in two clinical isolates of Pseudomonas aer...
Pseudomonas aeruginosa is a leading cause of disease and death particularly in cystic fibrosis patie...
minocycline, against 120 isolates of Pseudomonas aeruginosa was examined. In addition, the efficacy ...
The in vitro activity of meropenem was compared with those of six other antimicrobials against up to...
Aztreonam, ceftriaxone, moxalactam, cefotaxime, cefsulodin, cefoperazone, piperacillin, azlocillin, ...
Introduction Pseudomonas aeruginosa isolates related to nosocomial infections are often resistant to...
Imipenem was examined with standardized agar dilution procedures against a wide range of bacteria. G...
OBJECTIVE: To investigate the relationship between ciprofloxacin or imipenem use and antimicrobial r...
Imipenem-resistant Pseudomonas aeruginosa (IRPA) infection is a serious problem in hospitals. Combin...
Pseudomonas aeruginosa is a leading human pathogen that causes serious infections at various tissues...
Imipenem and imipenem-relebactam MICs were determined for 1,445 Pseudomonas aeruginosa clinical isol...
Combination therapy has been recommended to treat Pseudomonas aeruginosa infections worldwide. The p...
The efficacy of ceftazidime, piperacillin, tobramycin and ticarcillin was tested in vitro against 10...
Therapy for endocarditis due to Pseudomonas aeruginosa is complicated by the emergence of resistance...
ABSTRACTÂ We studied the susceptibility of 88 non-repetitive clinical isolates of Pseudomonas aerugi...
Emergence of resistance to fluoroquinolones was observed in two clinical isolates of Pseudomonas aer...
Pseudomonas aeruginosa is a leading cause of disease and death particularly in cystic fibrosis patie...
minocycline, against 120 isolates of Pseudomonas aeruginosa was examined. In addition, the efficacy ...
The in vitro activity of meropenem was compared with those of six other antimicrobials against up to...
Aztreonam, ceftriaxone, moxalactam, cefotaxime, cefsulodin, cefoperazone, piperacillin, azlocillin, ...
Introduction Pseudomonas aeruginosa isolates related to nosocomial infections are often resistant to...
Imipenem was examined with standardized agar dilution procedures against a wide range of bacteria. G...
OBJECTIVE: To investigate the relationship between ciprofloxacin or imipenem use and antimicrobial r...
Imipenem-resistant Pseudomonas aeruginosa (IRPA) infection is a serious problem in hospitals. Combin...
Pseudomonas aeruginosa is a leading human pathogen that causes serious infections at various tissues...
Imipenem and imipenem-relebactam MICs were determined for 1,445 Pseudomonas aeruginosa clinical isol...
Combination therapy has been recommended to treat Pseudomonas aeruginosa infections worldwide. The p...
The efficacy of ceftazidime, piperacillin, tobramycin and ticarcillin was tested in vitro against 10...
Therapy for endocarditis due to Pseudomonas aeruginosa is complicated by the emergence of resistance...
ABSTRACTÂ We studied the susceptibility of 88 non-repetitive clinical isolates of Pseudomonas aerugi...
Emergence of resistance to fluoroquinolones was observed in two clinical isolates of Pseudomonas aer...
Pseudomonas aeruginosa is a leading cause of disease and death particularly in cystic fibrosis patie...